此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Physical Activity Through Health Technology in Axial Spondyloarthritis

2026年6月9日 更新者:Rachael Stovall、University of Washington

Expanding Access to Early Exercise Prescriptions for Underserved Patients With Axial Spondyloarthritis: A Digital Health Approach

The purpose of this study is to find out whether a mobile app called the ExerciseRx app is a practical and helpful way for people with axial spondyloarthritis (axSpA) to receive exercise recommendations as part of their regular rheumatology care.

Researchers want to learn:

Whether people with axSpA find the ExerciseRx app easy to use and helpful for supporting regular exercise.

Whether using the ExerciseRx app leads to improvements in symptoms, physical function, and disease activity compared with usual care.

Participants assigned to the ExerciseRx group will use the app to complete guided exercises for 20-30 minutes, four times per week. They will also receive personalized weekly step-count goals to help increase their physical activity. Researchers will compare outcomes between participants using the app and those receiving usual care.

研究概览

研究类型

介入性

注册 (估计的)

40

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

  • 姓名:Joy Chan
  • 电话号码:206-744-3626
  • 邮箱:joychan@uw.edu

学习地点

    • Washington
      • Seattle、Washington、美国、98195
        • 招聘中
        • University of Washington
        • 接触:
      • Seattle、Washington、美国、98104
        • 招聘中
        • Harborview Medical Center
        • 接触:
        • 首席研究员:
          • Rachael Stovall, MD, MAS

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人
  • 年长者

接受健康志愿者

不

描述

Inclusion Criteria:

  • Diagnosis of axial spondyloarthritis by a rheumatologist
  • English speaking
  • Insufficiently active (less than 150 minutes of moderate intensity aerobic activity per week)
  • Willing to wear a Fitbit for the study duration
  • Willing to have or create a Google account and download the Google Health app (previously known as the Fitbit app)

Exclusion Criteria:

  • Currently pregnant
  • International travel or any circumstance causing lack of access to wi-fi/Internet at any point during the study period
  • Recent or planned surgery that may affect ability to engage in physical activity
  • Unable to exercise for health reasons, or a provider has recommended against exercising for safety/health reasons
  • Unable to walk safely without difficulty, or is a fall risk (i.e., 3+ falls in past 6 months)
  • History of a fall resulting in a fracture or head injury in the past 6 months
  • Cardiovascular contraindicators for physical activity, or history of cardiovascular problems that may be exacerbated by physical activity, as defined by their rheumatologist
  • Diabetes causing hypoglycemia following physical activity

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:单身的

武器和干预

参与者组/臂
干预/治疗
实验性的:ExerciseRx app
the ExerciseRx app with personalized exercise recommendations, an educational handout, Fitbit-guided step goals, and physical therapy referral
Patients complete home exercise sessions given via the ExerciseRx app over 20-30 minutes 4 times per week for 12 weeks and receive daily step count goals. Patients also receive a FitBit to wear continuously throughout the study, and are given access to view their step counts via the ExerciseRx app, and receive an educational handout with exercises for axial spondyloarthritis.
有源比较器:Usual care
An educational handout, Fitbit monitoring without step goals, and physical therapy referral
Patients receive recommendations from their physicians to continue their usual physical activity as tolerated, receive a FitBit to wear continuously throughout the study, with the ExerciseRx app locked to the baseline home screen, and receive an educational handout with exercises for axial spondyloarthritis.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Average minutes of physical activity/exercise during the week and % of participants with adherence to 60% or higher of the recommended exercises
大体时间:Week 0 (baseline), 6 and 12
We will measure feasibility by adherence to the recommended exercises in the intervention arm, including any additional reported physical activity throughout each week. In the usual care arm, participants will report any physical therapy exercises completed from the handout, as well as other physical activity/exercise. Adherence will be measured using the modified Short QUestionnaire to ASsess Health-enhancing physical activity (mSQUASH), a validated tool for capturing physical activity in axSpA. For those in the intervention arm, adherence will also be captured via the built-in tracking features of the ExerciseRx app, providing an additional measure of feasibility. Adherence or engagement with the ExerciseRx app will be measured in three domains: frequency of app use, adherence to recommended exercises, and interaction with behavioral features.
Week 0 (baseline), 6 and 12
Acceptability of the ExeriseRx app as a platform to complete recommended exercises for axial spondyloarthritis including % of participants with average score above 5 on MAUQ indicating usability
大体时间:Weeks 6 and 12
We will measure acceptability using the mHealth App Usability Questionnaire (MAUQ). Scores range from 1 to 7 with scores above 5 on a 7-point Likert scale considered to show usability.
Weeks 6 and 12

次要结果测量

结果测量
措施说明
大体时间
Change in disease activity over 12 weeks
大体时间:Weeks 0 (baseline), 6, and 12
We will measure changes in disease activity over the course of the study with Bath Axial Spondyloarthritis Disease Activity Index (BASDAI), a validated measure in axSpA. BASDAI ranges from 0-10 with 0 indicating remission and 10 indicated very high disease activity.
Weeks 0 (baseline), 6, and 12
Change in functional status
大体时间:Weeks 0 (baseline), 6, and 12
We will measure changes in functional status over the course of the study via the Bath Axial Spondyloarthritis Functional Index (BASFI), a validated measure in axSpA. BASFI ranges from 0-10 with 0 indicating full function and 10 indicating severe functional impairment.
Weeks 0 (baseline), 6, and 12

其他结果措施

结果测量
措施说明
大体时间
Barriers and facilitators to physical activity/exercise
大体时间:Weekly throughout the 12 week study
Participants will receive weekly surveys from the ExerciseRx app regarding any barriers and facilitator to physical activity/exercise during the week.
Weekly throughout the 12 week study

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Rachael Stovall, MD、University of Washington

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2026年6月1日

初级完成 (估计的)

2027年4月1日

研究完成 (估计的)

2027年6月1日

研究注册日期

首次提交

2026年6月3日

首先提交符合 QC 标准的

2026年6月9日

首次发布 (实际的)

2026年6月11日

研究记录更新

最后更新发布 (实际的)

2026年6月11日

上次提交的符合 QC 标准的更新

2026年6月9日

最后验证

2026年6月1日

更多信息

与本研究相关的术语

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

在美国制造并从美国出口的产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅